In addition, TFRC overexpression can be associated with poor prognosis and is considered an effective prognostic marker in different types of cancer, such as esophageal squamous cell carcinoma [21], breast cancer [28, 29], renal cell carcinoma [30], and hepatocellular carcinoma [31]. This evidence concerns the gene TFRC and breast carcinoma.